Pub Date : 2026-03-01DOI: 10.1038/s41551-026-01646-2
Rita Strack
{"title":"mRNA delivery to the endothelium.","authors":"Rita Strack","doi":"10.1038/s41551-026-01646-2","DOIUrl":"https://doi.org/10.1038/s41551-026-01646-2","url":null,"abstract":"","PeriodicalId":19063,"journal":{"name":"Nature Biomedical Engineering","volume":"10 3","pages":"409"},"PeriodicalIF":26.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147504410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-20DOI: 10.1038/s41551-026-01626-6
The purpose of the presubmission enquiry can be a point of confusion for our authors and can vary across journals. This month we hope to demystify its role in the editorial pipeline at Nature Biomedical Engineering.
{"title":"The presubmission enquiry","authors":"","doi":"10.1038/s41551-026-01626-6","DOIUrl":"10.1038/s41551-026-01626-6","url":null,"abstract":"The purpose of the presubmission enquiry can be a point of confusion for our authors and can vary across journals. This month we hope to demystify its role in the editorial pipeline at Nature Biomedical Engineering.","PeriodicalId":19063,"journal":{"name":"Nature Biomedical Engineering","volume":"10 2","pages":"193-194"},"PeriodicalIF":26.8,"publicationDate":"2026-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.nature.comhttps://www.nature.com/articles/s41551-026-01626-6.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146224571","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-20DOI: 10.1038/s41551-026-01625-7
Valeria Caprettini
{"title":"Decoding the DNA repair toolkit of the bowhead whale","authors":"Valeria Caprettini","doi":"10.1038/s41551-026-01625-7","DOIUrl":"10.1038/s41551-026-01625-7","url":null,"abstract":"","PeriodicalId":19063,"journal":{"name":"Nature Biomedical Engineering","volume":"10 2","pages":"195-195"},"PeriodicalIF":26.8,"publicationDate":"2026-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146224570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-18DOI: 10.1038/s41551-026-01620-y
Naijia Liu, Shahrzad Shiravi, Tianqi Jin, Jiaqi Liu, Zhengguang Zhu, Jiying Li, Ingrid Cheung, Haohui Zhang, Yue Wang, Qingyuan Li, Zijie Xu, Liangsong Zeng, Maria Jose Quezada, Andres Villalobos, Yasaman Samei, Shreyaa Khanna, Shuozhen Bao, Mingzheng Wu, Sida Liang, Xu Cheng, Zengyao Lv, Woo-Youl Maeng, Yamin Zhang, Haiwen Luan, Stephen A. Boppart, Yonggang Huang, Yihui Zhang, Colin K. Franz, John D. Finan, John A. Rogers
{"title":"Shape-conformal porous frameworks for full coverage of neural organoids and high-resolution electrophysiology","authors":"Naijia Liu, Shahrzad Shiravi, Tianqi Jin, Jiaqi Liu, Zhengguang Zhu, Jiying Li, Ingrid Cheung, Haohui Zhang, Yue Wang, Qingyuan Li, Zijie Xu, Liangsong Zeng, Maria Jose Quezada, Andres Villalobos, Yasaman Samei, Shreyaa Khanna, Shuozhen Bao, Mingzheng Wu, Sida Liang, Xu Cheng, Zengyao Lv, Woo-Youl Maeng, Yamin Zhang, Haiwen Luan, Stephen A. Boppart, Yonggang Huang, Yihui Zhang, Colin K. Franz, John D. Finan, John A. Rogers","doi":"10.1038/s41551-026-01620-y","DOIUrl":"https://doi.org/10.1038/s41551-026-01620-y","url":null,"abstract":"","PeriodicalId":19063,"journal":{"name":"Nature Biomedical Engineering","volume":"11 1","pages":""},"PeriodicalIF":28.1,"publicationDate":"2026-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146210317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-13DOI: 10.1038/s41551-026-01619-5
Yue Zhang, Chen Li, Ruijie Deng
{"title":"Rapid quantification of both fungal abundance and drug resistance via reaction kinetics.","authors":"Yue Zhang, Chen Li, Ruijie Deng","doi":"10.1038/s41551-026-01619-5","DOIUrl":"https://doi.org/10.1038/s41551-026-01619-5","url":null,"abstract":"","PeriodicalId":19063,"journal":{"name":"Nature Biomedical Engineering","volume":" ","pages":""},"PeriodicalIF":26.8,"publicationDate":"2026-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146195177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-12DOI: 10.1038/s41551-025-01599-y
Ibrahim Ethem Hamamci, Sezgin Er, Chenyu Wang, Furkan Almas, Ayse Gulnihan Simsek, Sevval Nil Esirgun, Irem Dogan, Omer Faruk Durugol, Benjamin Hou, Suprosanna Shit, Weicheng Dai, Murong Xu, Hadrien Reynaud, Muhammed Furkan Dasdelen, Bastian Wittmann, Tamaz Amiranashvili, Enis Simsar, Mehmet Simsar, Emine Bensu Erdemir, Abdullah Alanbay, Anjany Sekuboyina, Berkan Lafci, Ahmet Kaplan, Zhiyong Lu, Malgorzata Polacin, Bernhard Kainz, Christian Bluethgen, Kayhan Batmanghelich, Mehmet Kemal Ozdemir, Bjoern Menze
Advancements in medical imaging AI, particularly in 3D imaging, have been limited due to the scarcity of comprehensive datasets. We introduce CT-RATE, a public dataset that pairs 3D medical images with corresponding textual reports. CT-RATE comprises 25,692 non-contrast 3D chest CT scans from 21,304 unique patients. Each scan is accompanied by its corresponding radiology report. Leveraging CT-RATE, we develop CT-CLIP, a CT-focused contrastive language-image pretraining framework designed for broad applications without the need for task-specific training. We demonstrate how CT-CLIP can be used in multi-abnormality detection and case retrieval, and outperforms state-of-the-art fully supervised models across all key metrics. By combining CT-CLIP's vision encoder with a pretrained large language model, we create CT-CHAT, a vision-language foundational chat model for 3D chest CT volumes. Fine-tuned on over 2.7 million question-answer pairs derived from the CT-RATE dataset, CT-CHAT underscores the necessity for specialized methods in 3D medical imaging. Collectively, the open-source release of CT-RATE, CT-CLIP and CT-CHAT not only addresses critical challenges in 3D medical imaging but also lays the groundwork for future innovations in medical AI and improved patient care.
{"title":"Generalist foundation models from a multimodal dataset for 3D computed tomography.","authors":"Ibrahim Ethem Hamamci, Sezgin Er, Chenyu Wang, Furkan Almas, Ayse Gulnihan Simsek, Sevval Nil Esirgun, Irem Dogan, Omer Faruk Durugol, Benjamin Hou, Suprosanna Shit, Weicheng Dai, Murong Xu, Hadrien Reynaud, Muhammed Furkan Dasdelen, Bastian Wittmann, Tamaz Amiranashvili, Enis Simsar, Mehmet Simsar, Emine Bensu Erdemir, Abdullah Alanbay, Anjany Sekuboyina, Berkan Lafci, Ahmet Kaplan, Zhiyong Lu, Malgorzata Polacin, Bernhard Kainz, Christian Bluethgen, Kayhan Batmanghelich, Mehmet Kemal Ozdemir, Bjoern Menze","doi":"10.1038/s41551-025-01599-y","DOIUrl":"https://doi.org/10.1038/s41551-025-01599-y","url":null,"abstract":"<p><p>Advancements in medical imaging AI, particularly in 3D imaging, have been limited due to the scarcity of comprehensive datasets. We introduce CT-RATE, a public dataset that pairs 3D medical images with corresponding textual reports. CT-RATE comprises 25,692 non-contrast 3D chest CT scans from 21,304 unique patients. Each scan is accompanied by its corresponding radiology report. Leveraging CT-RATE, we develop CT-CLIP, a CT-focused contrastive language-image pretraining framework designed for broad applications without the need for task-specific training. We demonstrate how CT-CLIP can be used in multi-abnormality detection and case retrieval, and outperforms state-of-the-art fully supervised models across all key metrics. By combining CT-CLIP's vision encoder with a pretrained large language model, we create CT-CHAT, a vision-language foundational chat model for 3D chest CT volumes. Fine-tuned on over 2.7 million question-answer pairs derived from the CT-RATE dataset, CT-CHAT underscores the necessity for specialized methods in 3D medical imaging. Collectively, the open-source release of CT-RATE, CT-CLIP and CT-CHAT not only addresses critical challenges in 3D medical imaging but also lays the groundwork for future innovations in medical AI and improved patient care.</p>","PeriodicalId":19063,"journal":{"name":"Nature Biomedical Engineering","volume":" ","pages":""},"PeriodicalIF":26.8,"publicationDate":"2026-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146181256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-11DOI: 10.1038/s41551-025-01610-6
Janina Dörr, Lisa Gregor, Sebastian B. Lacher, Arman Oner, Yi Sun, Ignazio Piseddu, Luisa Fertig, Sebastijan Spajic, Stefanie Lesch, Stefanos Michaelides, Matthias Seifert, Adrian Gottschlich, Natasha Samson, Lina Majed, Daria Briukhovetska, Donjetë Simnica, Viktoria Hartmann, Kathrin Gabriel, Sonia Cohen, Genevieve M. Boland, David Andreu-Sanz, Emanuele Carlini, Sophia Stock, Anne Holtermann, Philipp Jie Müller, Thaddäus Strzalkowski, Marcel P. Trefny, Stefan Endres, Russell W. Jenkins, Jan P. Böttcher, Sebastian Kobold
The efficacy of chimeric antigen receptor (CAR) T cell therapy in solid cancers is limited by immunosuppression in the tumour microenvironment (TME). Prostaglandin E2 (PGE2) is a key factor locally inhibiting T cell function. We hypothesized that targeted ablation of PGE2 signalling in CAR T cells may enhance their activity in PGE2-rich solid tumours. Here we generate knockout CAR T cells double deficient for the PGE2 receptors EP2 and EP4 (EP2−/−EP4−/−) by CRISPR–Cas9 engineering. EP2−/−EP4−/− CAR T cells expanded unabatedly in the presence of PGE2. Further, they effectively controlled syngeneic and human xenograft tumour models in vivo, which was accompanied by intratumoural accumulation and persistence of modified T cells. Improved anti-tumour activity was also observed against patient-derived tumour samples from patients with pancreatic ductal adenocarcinoma (PDAC), colorectal (CRC) and neuroendocrine (NET) cancer. Our data uncovers the detrimental impact of PGE2-mediated suppression on CAR T cell efficacy and highlights EP2 and EP4 targeting as a potential strategy.
{"title":"Ablation of prostaglandin E2 signalling through dual receptor knockout in CAR T cells enhances therapeutic efficacy in solid tumours","authors":"Janina Dörr, Lisa Gregor, Sebastian B. Lacher, Arman Oner, Yi Sun, Ignazio Piseddu, Luisa Fertig, Sebastijan Spajic, Stefanie Lesch, Stefanos Michaelides, Matthias Seifert, Adrian Gottschlich, Natasha Samson, Lina Majed, Daria Briukhovetska, Donjetë Simnica, Viktoria Hartmann, Kathrin Gabriel, Sonia Cohen, Genevieve M. Boland, David Andreu-Sanz, Emanuele Carlini, Sophia Stock, Anne Holtermann, Philipp Jie Müller, Thaddäus Strzalkowski, Marcel P. Trefny, Stefan Endres, Russell W. Jenkins, Jan P. Böttcher, Sebastian Kobold","doi":"10.1038/s41551-025-01610-6","DOIUrl":"https://doi.org/10.1038/s41551-025-01610-6","url":null,"abstract":"The efficacy of chimeric antigen receptor (CAR) T cell therapy in solid cancers is limited by immunosuppression in the tumour microenvironment (TME). Prostaglandin E2 (PGE2) is a key factor locally inhibiting T cell function. We hypothesized that targeted ablation of PGE2 signalling in CAR T cells may enhance their activity in PGE2-rich solid tumours. Here we generate knockout CAR T cells double deficient for the PGE2 receptors EP2 and EP4 (EP2−/−EP4−/−) by CRISPR–Cas9 engineering. EP2−/−EP4−/− CAR T cells expanded unabatedly in the presence of PGE2. Further, they effectively controlled syngeneic and human xenograft tumour models in vivo, which was accompanied by intratumoural accumulation and persistence of modified T cells. Improved anti-tumour activity was also observed against patient-derived tumour samples from patients with pancreatic ductal adenocarcinoma (PDAC), colorectal (CRC) and neuroendocrine (NET) cancer. Our data uncovers the detrimental impact of PGE2-mediated suppression on CAR T cell efficacy and highlights EP2 and EP4 targeting as a potential strategy.","PeriodicalId":19063,"journal":{"name":"Nature Biomedical Engineering","volume":"140 1","pages":""},"PeriodicalIF":28.1,"publicationDate":"2026-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146152311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-11DOI: 10.1038/s41551-025-01606-2
Nozomu Takata, Zhiwei Li, Anna Metlushko, Feng Chen, Nicholas A. Sather, Xinyi Lin, Matthew J. Schipma, Oscar A. Carballo-Molina, Cassandre Jamroz, Madison E. Strong, Cara S. Smith, Yang Yang, Ching M. Wai, Neha Joshi, Jack Kolberg-Edelbrock, Kyle J. Gray, Suitu Wang, Liam C. Palmer, Samuel I. Stupp
Damage to the spinal cord can lead to irreversible paralysis and loss of sensory function, but translation of preclinical therapies remains elusive. We recently showed that bioactive supramolecular assemblies of peptide amphiphiles can reverse paralysis in an acute mouse model following severe spinal cord injury (SCI). Here we report the development of two human spinal cord organoid injury models to simulate SCI in vitro, a laceration of the organoid with a scalpel and a compressive contusion commonly used in preclinical models, both resulting in immediate neuronal death and the formation of glial scar-like tissue. Treatment of the injured organoids with the preclinical therapy suppressed the scar-like tissue and promoted significant axonal regeneration, as observed previously in vivo. With the inclusion of microglia into the spinal cord organoids, we demonstrate that the supramolecular nanomaterial reduced pro-inflammatory factors commonly associated with injury. The human spinal cord organoid models developed here could accelerate the discovery of therapies to treat SCI and possibly damage of other central nervous system tissues owing to trauma or disease.
{"title":"Injury and therapy in a human spinal cord organoid","authors":"Nozomu Takata, Zhiwei Li, Anna Metlushko, Feng Chen, Nicholas A. Sather, Xinyi Lin, Matthew J. Schipma, Oscar A. Carballo-Molina, Cassandre Jamroz, Madison E. Strong, Cara S. Smith, Yang Yang, Ching M. Wai, Neha Joshi, Jack Kolberg-Edelbrock, Kyle J. Gray, Suitu Wang, Liam C. Palmer, Samuel I. Stupp","doi":"10.1038/s41551-025-01606-2","DOIUrl":"https://doi.org/10.1038/s41551-025-01606-2","url":null,"abstract":"Damage to the spinal cord can lead to irreversible paralysis and loss of sensory function, but translation of preclinical therapies remains elusive. We recently showed that bioactive supramolecular assemblies of peptide amphiphiles can reverse paralysis in an acute mouse model following severe spinal cord injury (SCI). Here we report the development of two human spinal cord organoid injury models to simulate SCI in vitro, a laceration of the organoid with a scalpel and a compressive contusion commonly used in preclinical models, both resulting in immediate neuronal death and the formation of glial scar-like tissue. Treatment of the injured organoids with the preclinical therapy suppressed the scar-like tissue and promoted significant axonal regeneration, as observed previously in vivo. With the inclusion of microglia into the spinal cord organoids, we demonstrate that the supramolecular nanomaterial reduced pro-inflammatory factors commonly associated with injury. The human spinal cord organoid models developed here could accelerate the discovery of therapies to treat SCI and possibly damage of other central nervous system tissues owing to trauma or disease.","PeriodicalId":19063,"journal":{"name":"Nature Biomedical Engineering","volume":"6 1","pages":""},"PeriodicalIF":28.1,"publicationDate":"2026-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146152314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：